Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 522

1.

Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy.

Li LX, Scolyer RA, Ka VS, McKinnon JG, Shaw HM, McCarthy SW, Thompson JF.

Am J Surg Pathol. 2003 Sep;27(9):1197-202.

PMID:
12960803
2.

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.

Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS.

Am J Surg Pathol. 2005 Mar;29(3):305-17.

PMID:
15725798
3.

Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.

Manca G, Romanini A, Pellegrino D, Borsò E, Rondini M, Orlandini C, Zucchi V, Pasqualetti F, Mariani G.

J Nucl Med. 2008 Nov;49(11):1769-75. doi: 10.2967/jnumed.108.055350. Epub 2008 Oct 16.

4.

Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.

Murali R, DeSilva C, McCarthy SW, Thompson JF, Scolyer RA.

Ann Surg Oncol. 2012 Apr;19(4):1089-99. doi: 10.1245/s10434-011-2208-z. Epub 2012 Jan 21.

PMID:
22271204
5.

Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.

Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B.

Arch Otolaryngol Head Neck Surg. 2007 Aug;133(8):820-6.

PMID:
17709624
6.

Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens.

Scolyer RA, Li LX, McCarthy SW, Shaw HM, Stretch JR, Sharma R, Thompson JF.

Melanoma Res. 2004 Aug;14(4):263-8.

PMID:
15305156
7.

Idiosyncrasies of scalp melanoma.

Rigual NR, Cheney RT, Iwenofu OH, Li Q, Loree TR, Popat SR, Merzianu M.

Laryngoscope. 2007 Aug;117(8):1354-8.

PMID:
17592396
8.

Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.

Creager AJ, Shiver SA, Shen P, Geisinger KR, Levine EA.

Cancer. 2002 Jun 1;94(11):3016-22.

9.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
10.

Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?

Karimipour DJ, Lowe L, Su L, Hamilton T, Sondak V, Johnson TM, Fullen D.

J Am Acad Dermatol. 2004 May;50(5):759-64.

PMID:
15097961
11.

Rapid immunohistochemistry of sentinel lymph nodes for metastatic melanoma.

Eudy GE, Carlson GW, Murray DR, Waldrop SM, Lawson D, Cohen C.

Hum Pathol. 2003 Aug;34(8):797-802.

PMID:
14506642
12.

Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.

Gannon CJ, Rousseau DL Jr, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE.

Cancer. 2006 Dec 1;107(11):2647-52.

13.

Intraoperative touch imprint cytological analysis of sentinel lymph nodes for the presence of metastases in malignant melanoma.

Tamiolakis D, Venizelos J, Jivanakis T, Antoniou C, Economou C, Tsiminikakis N, Georgiou G, Alexiadis G, Costopoulou A.

Minerva Med. 2008 Feb;99(1):15-21.

PMID:
18299693
14.

Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?

Smith J, Hwang H, Wiseman KW, Filipenko D, Phang PT.

Am J Surg. 2006 May;191(5):665-8.

PMID:
16647356
15.

Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes.

Gibbs JF, Huang PP, Zhang PJ, Kraybill WG, Cheney R.

Ann Surg Oncol. 1999 Oct-Nov;6(7):699-704.

PMID:
10560857
16.

Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.

Denninghoff VC, Kahn AG, Falco J, Curutchet HP, Elsner B.

Mol Diagn. 2004;8(4):253-8.

PMID:
15887981
17.

Regional recurrence after negative sentinel lymph node biopsy for melanoma.

Carlson GW, Page AJ, Cohen C, Parker D, Yaar R, Li A, Hestley A, Delman KA, Murray DR.

Ann Surg. 2008 Sep;248(3):378-86. doi: 10.1097/SLA.0b013e3181855718.

PMID:
18791358
18.

Frozen section analysis of sentinel lymph nodes in melanoma patients.

Koopal SA, Tiebosch AT, Albertus Piers D, Plukker JT, Schraffordt Koops H, Hoekstra HJ.

Cancer. 2000 Oct 15;89(8):1720-5.

PMID:
11042566
19.

Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.

Ulmer A, Fischer JR, Schanz S, Sotlar K, Breuninger H, Dietz K, Fierlbeck G, Klein CA.

Clin Cancer Res. 2005 Aug 1;11(15):5425-32.

20.

Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.

Mangas C, Hilari JM, Paradelo C, Rex J, Fernández-Figueras MT, Fraile M, Alastrue A, Ferrándiz C.

Ann Surg Oncol. 2006 Jul;13(7):910-8. Epub 2006 May 22.

PMID:
16788751

Supplemental Content

Support Center